Biomarkers in Post-kala-azar Dermal Leishmaniasis.
Zijlstra EE.
Front Cell Infect Microbiol. 2019 Jul 31;9:228. doi: 10.3389/fcimb.2019.00228. eCollection 2019.
Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
Kumar A, Singh VK, Tiwari R, Madhukar P, Rajneesh, Kumar S, Gautam V, Engwerda C, Sundar S, Kumar R.
Front Immunol. 2023 Aug 11;14:1236952. doi: 10.3389/fimmu.2023.1236952. eCollection 2023.
Post-kala-azar dermal leishmaniasis.
Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM.
Lancet Infect Dis. 2003 Feb;3(2):87-98. doi: 10.1016/s1473-3099(03)00517-6.
Post-kala-azar dermal leishmaniasis: a global overview.
Ghosh C, Karmakar C, Sarkar D, Goswami D, Roy M, Sengupta S, Chaudhuri SJ, Roy S, Dutta B, Das A, Das NK, Chatterjee M.
Clin Exp Dermatol. 2026 Apr 24;51(5):789-804. doi: 10.1093/ced/llag010.
Post-kala-azar dermal leishmaniasis--an overview.
Ganguly S, Das NK, Barbhuiya JN, Chatterjee M.
Int J Dermatol. 2010 Aug;49(8):921-31. doi: 10.1111/j.1365-4632.2010.04558.x.
Post-kala-azar dermal leishmaniasis.
Ramesh V, Mukherjee A.
Int J Dermatol. 1995 Feb;34(2):85-91. doi: 10.1111/j.1365-4362.1995.tb03584.x.
Post kala-azar dermal leishmaniasis: A threat to elimination program.
Gedda MR, Singh B, Kumar D, Singh AK, Madhukar P, Upadhyay S, Singh OP, Sundar S.
PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008221. doi: 10.1371/journal.pntd.0008221. eCollection 2020 Jul.
Post-Kala-Azar Dermal Leishmaniasis.
Sharma A, Bishnoi A, Parsad D.
Am J Trop Med Hyg. 2024 Jul 23;111(4):710-712. doi: 10.4269/ajtmh.24-0018. Print 2024 Oct 2.
Post-kala-azar dermal leishmaniasis.
Pathania YS, Budania A.
QJM. 2022 Jan 5;114(11):824-825. doi: 10.1093/qjmed/hcab236.
Post-kala-azar dermal leishmaniasis: recent developments.
Singh S, Sharma U, Mishra J.
Int J Dermatol. 2011 Sep;50(9):1099-108. doi: 10.1111/j.1365-4632.2011.04925.x.
